ANGLE plc (GB:AGL) has released an update.
ANGLE plc, a leader in liquid biopsy solutions, has successfully raised £9.3m through an Open Offer, Placing, and Subscription, with the immediate Open Offer contributing £0.5m. The funds are set to bolster the company’s balance sheet and support its innovative cancer diagnostic technologies. The new shares from the Open Offer are expected to be tradable on the AIM market starting 24 June 2024.
For further insights into GB:AGL stock, check out TipRanks’ Stock Analysis page.
